169 related articles for article (PubMed ID: 8823423)
1. A controlled trial of a 4-weekly supplement of rifampicin, pyrazinamide and streptomycin in the continuation phase of a 7-month daily chemotherapy regimen for pulmonary tuberculosis. Tanzania/British Medical Research Council Collaborative Investigation.
S Afr Med J; 1996 Aug; 86(8):960-5. PubMed ID: 8823423
[TBL] [Abstract][Full Text] [Related]
2. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.
Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199
[TBL] [Abstract][Full Text] [Related]
3. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200
[TBL] [Abstract][Full Text] [Related]
4. Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis: final report. East and Central African/British Medical Research Council Fifth Collaborative Study.
Tubercle; 1986 Mar; 67(1):5-15. PubMed ID: 3521015
[TBL] [Abstract][Full Text] [Related]
5. Controlled clinical trial of 4 short-couse regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis.
Tubercle; 1983 Sep; 64(3):153-66. PubMed ID: 6356538
[TBL] [Abstract][Full Text] [Related]
6. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
Wada M
Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
[TBL] [Abstract][Full Text] [Related]
7. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report.
Am Rev Respir Dis; 1978 Aug; 118(2):219-28. PubMed ID: 100029
[TBL] [Abstract][Full Text] [Related]
8. Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
Am Rev Respir Dis; 1988 May; 137(5):1147-50. PubMed ID: 2904237
[TBL] [Abstract][Full Text] [Related]
9. Controlled trial of 6- and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong.
Tubercle; 1975 Jun; 56(2):81-96. PubMed ID: 1103400
[TBL] [Abstract][Full Text] [Related]
10. Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis. Second report. Third East African/British Medical Research Council Study.
Tubercle; 1980 Jun; 61(2):59-69. PubMed ID: 6159711
[TBL] [Abstract][Full Text] [Related]
11. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report.
Teo SK
Int J Tuberc Lung Dis; 1999 Feb; 3(2):126-32. PubMed ID: 10091877
[TBL] [Abstract][Full Text] [Related]
12. Five year results of a 3-month and two 5-month regimens for the treatment of sputum-positive pulmonary tuberculosis in south India.
Balasubramanian R; Sivasubramanian S; Vijayan VK; Ramachandran R; Jawahar MS; Paramasivan CN; Selvakumar N; Somasundaram PR
Tubercle; 1990 Dec; 71(4):253-8. PubMed ID: 2125153
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
Am Rev Respir Dis; 1985 Aug; 132(2):374-8. PubMed ID: 2862820
[TBL] [Abstract][Full Text] [Related]
14. Sputum-smear-negative pulmonary tuberculosis: controlled trial of 3-month and 2-month regimens of chemotherapy.
Lancet; 1979 Jun; 1(8131):1361-3. PubMed ID: 87829
[TBL] [Abstract][Full Text] [Related]
15. Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. Second report of the 4th study. East African/British Medical Research Councils Study.
Am Rev Respir Dis; 1981 Feb; 123(2):165-70. PubMed ID: 7015933
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis.
Am Rev Respir Dis; 1979 Apr; 119(4):579-85. PubMed ID: 375787
[TBL] [Abstract][Full Text] [Related]
17. Controlled trial of 4 three-times-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Second report: the results up to 24 months. Hong Kong Chest Service/British Medical Research Council.
Tubercle; 1982 Jun; 63(2):89-98. PubMed ID: 6758252
[TBL] [Abstract][Full Text] [Related]
18. Short-course chemotherapy for pulmonary tuberculosis under routine programme conditions: a comparison of regimens of 28 and 36 weeks duration in Algeria. Algerian Working Group/British Medical Research Council Cooperative Study.
Tubercle; 1991 Jun; 72(2):88-100. PubMed ID: 1949222
[TBL] [Abstract][Full Text] [Related]
19. Controlled clinical trial of three short-course regimens of chemotherapy for pulmonary tuberculosis in Nigeria--a preliminary report.
Onadeko BO; Awotedu AA; Ogunbanjo BO; Aderinto EB
Tubercle; 1986 Sep; 67(3):189-95. PubMed ID: 3535187
[TBL] [Abstract][Full Text] [Related]
20. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
Jawahar MS; Rajaram K; Sivasubramanian S; Paramasivan CN; Chandrasekar K; Kamaludeen MN; Thirithuvathas AJ; Ananthalakshmi V; Prabhakar R
Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
